The Medtronic Newsroom is designed to assist media in finding news and information about our company.

Medtronic, founded in a Minneapolis garage in 1949 by Earl Bakken and his brother-in-law, Palmer Hermundslie, is the world’s leading maker of medical devices.

Our Mission has not changed since Earl Bakken wrote it in 1960: To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health and extend life.

More than 9 million lives are enhanced every year by a Medtronic product or therapy; that’s one every three seconds.

Medtronic is headquartered in Minneapolis, MN and operates in more than 140 countries. The company employs 49,000 people, including 5,800 scientists and engineers, pursuing research and innovation that has led to more than 28,000 patents.

Most Recent Press ReleasesRead More
09/29/14Medtronic Extends Title Sponsorship of Twin Cities Marathon Through 2020
Building on Nearly a Decade of Growth, Partnership Allows Twin Cities In Motion to Continue to Expand and Enhance Race Events and Youth Programming MINNEAPOLIS - Sept. 29, 2014 -Medtronic and Twin Cities In Motion, the organizers of the Medtronic Twin Cities Marathon, today announced a five-year, $2.5 million agreement that will keep Medtronic as the title sponsor of the Twin Cities Marathon and three additional Twin Cities In Motion events through 2020: the TC 1 Mile, TC Family Events, and TC ... 
09/25/14Medtronic Announces $6 Million Philanthropic Effort to Prevent and Control Rheumatic Heart Disease
$6 Million Marks the Largest Private-Sector Contribution to Date to Address One of the World's Most Neglected, Yet Preventable, Diseases Affecting the World's Poor MINNEAPOLIS - September 25, 2014 - Medtronic today announced a five-year, $6 million (USD) funding commitment from Medtronic Philanthropy to reduce premature mortality resulting from Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD). Funding will support projects focused in three countries yet to be determined.  The commitment... 
09/22/14Medtronic Announces CE Mark and European Launch of TYRX(TM) Absorbable Antibacterial Envelope
MINNEAPOLIS - Sept. 22, 2014 - Medtronic, Inc. (NYSE: MDT) has received CE (Conformité Européenne) Mark for the TYRX(TM) Absorbable Antibacterial Envelope. This innovative mesh envelope covers an implantable cardiac device to help stabilize the device after implantation and reduce surgical-site infections. The efficacy of the previous generation, non-absorbable TYRX(TM) Antibacterial Envelope* has been shown in three published studies, with new six-month follow-up data from the CITADEL/CENTURI... 
Medtronic in the News
05/03/14Med-Tech Industry is Booming in China – Minneapolis Star Tribune
02/18/14The 50 Smartest Companies for 2014 – MIT Technology Review
02/18/14Innovation is just what the doctor ordered – Shanghai Daily
Receive E-mail Alerts E-mail Alert Icon
Sign up to receive e-mail alerts whenever Medtronic posts new information to the site. Just enter your e-mail address and click Submit.

Section Navigation


Medtronic to acquire Covidien. Learn More.

Media contact:
Fernando Vivanco


Contact Us

Medtronic, Inc.
main number(763) 514-4000
Public Relations
710 Medtronic Pkwy NE LC-110
Minneapolis, MN  55432

Media Contacts

Latest Tweets

Medtronic News

Latest Tweets

Omar Ishrak